Biohit Starts Two Clinical Trials With Acetium® Capsule For Prevention Of Migraine-Type Headache
4/29/2014 9:10:04 AM
Biohit Oyj initiates two clinical trials for prevention of migraine-type headache attacks, testing the efficacy of Acetium® capsule in novel clinical indications. The purpose of the trial is to assess the effect of Acetium® capsule in prevention of headache attacks among patients suffering from migraine or cluster/Horton headache. Both studies will be conducted as multi-center clinical trials in collaboration with Terveystalo Oy and Aava Medical Center altogether in six cities in Finland.
Help employers find you! Check out all the jobs and post your resume.
comments powered by